financetom
Business
financetom
/
Business
/
Amylyx to stop development of rare brain disorder drug after trial failure
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amylyx to stop development of rare brain disorder drug after trial failure
Aug 27, 2025 4:35 AM

Aug 27 (Reuters) - Amylyx Pharmaceuticals ( AMLX ) said

on Wednesday it will discontinue development of its experimental

drug for a rare brain disorder after the treatment failed to

show benefit in a mid-stage trial.

(Reporting by Kamal Choudhury in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved